Strep Throat Treatment Market Report 2026

Strep Throat Treatment Market Overview

• Strep Throat Treatment market size has reached to $2.19 billion in 2025 • Expected to grow to $2.81 billion in 2030 at a compound annual growth rate (CAGR) of 5% • Growth Driver: Rising Incidence Of Bacterial Infections Drives Growth In Strep Throat Treatment Market • Market Trend: Major Companies Are Developing Rapid Diagnostics To Improve Strep Throat Treatment And Reduce Antibiotic Misuse • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Strep Throat Treatment Market?

Strep throat refers to a bacterial infection caused by Group A Streptococcus bacteria. It typically affects the throat and tonsils, causing symptoms such as a sore throat, difficulty swallowing, fever, swollen lymph nodes, and sometimes white patches on the tonsils. Strep throat is typically treated with antibiotics such as penicillin or amoxicillin, along with pain relievers, rest, and fluids to manage symptoms, prevent complications, and promote recovery. The main types of strep throat treatment include antibiotics, pain relievers, and others. Antibiotics refer to medications that kill or inhibit the growth of bacteria and act as the primary treatment for strep throat, targeting the streptococci bacteria responsible for the infection. The diagnosis type includes an antibody test, a physical examination, a throat culture, Others and routes of administration are categorized as oral, topical, and injectable for disease types such as acute strep throat, pharyngitis, tonsillitis, laryngitis, and others. The end users included are hospitals, specialty clinics, diagnostic laboratories, and others.

What Is The Strep Throat Treatment Market Growth Forecast?

The strep throat treatment market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to rising focus on antimicrobial resistance management, increasing use of rapid point-of-care diagnostics, expansion of telehealth consultations, growing demand for accurate early diagnosis, increasing investments in infectious disease research. Major trends in the forecast period include increasing adoption of rapid diagnostic testing, rising focus on antibiotic stewardship programs, growing use of combination therapy approaches, expansion of telemedicine-based diagnosis, enhanced patient awareness and early treatment.

Global Strep Throat Treatment Market Segmentation

1) By Treatment Type: Antibiotics, Pain Relievers, Other Treatment Type 2) By Diagnosis: Antibody Test, Physical Examination, Throat Culture, Other Diagnosis 3) By Route Of Administration: Oral, Topical, Injectable 4) By Disease Type: Acute Strep Throat, Pharyngitis, Tonsillitis, Laryngitis, Other Disease Type 5) By End-Users: Hospitals, Specialty Clinics, Diagnostic Laboratories, Other End-Users Subsegments: 1) By Antibiotics: Penicillin-Based Antibiotics, Amoxicillin-Based Antibiotics, Cephalosporins, Macrolides 2) By Pain Relievers: Non-Steroidal Anti-Inflammatory Drugs (Nsaids), Acetaminophen, Topical Throat Sprays Or Lozenges 3) By Other Treatment Types: Corticosteroids, Herbal Remedies, Saltwater Gargles And Other Home Remedies

What Are The Drivers Of The Strep Throat Treatment Market?

The rising incidence of bacterial infections is expected to propel the growth of the strep throat treatment market going forward. Bacterial infections are diseases caused by harmful bacteria that invade the body, multiply, and produce toxins. The rise in bacterial infections stems from antibiotic overuse, global travel, urbanization, poor hygiene, and healthcare-associated infections. Strep throat treatment addresses bacterial infections by providing effective medication and care, thereby alleviating symptoms, reducing the duration of illness, and preventing complications while helping healthcare providers manage patient outcomes and combat the spread of infections. For instance, in June 2023, according to a report published by the Office for Health Improvement and Disparities, a UK-based governmental body, a total of 4,622 notifications of scarlet fever Group A Streptococcus bacteria were received from week 37 to week 46 during the 2022-2023 season in England, with 851 notifications received in week 46 alone. This is significantly higher than an average of 1,294 notifications (ranging from 258 to 2,008) for the same period (weeks 37 to 46) over the previous five years. Therefore, a rising incidence of bacterial infections is driving the strep throat treatment industry. The rising healthcare expenditure is expected to propel the growth of the strep throat treatment market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Healthcare expenditure improves strep throat treatment by enabling timely diagnostics, affordable antibiotics, trained care, public health programs, and research to prevent complications and ensure wider access. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the strep throat treatment industry.

Key Players In The Global Strep Throat Treatment Market

Major companies operating in the strep throat treatment market are Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc GSK, C.H. Boehringer Sohn AG And Co. KG, Eli Lilly and Company, Amgen Inc., Reckitt Benckiser Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Mylan N.V

Global Strep Throat Treatment Market Trends and Insights

Major companies operating in the strep throat treatment market are developing new treatment solutions, such as rapid throat infection diagnostics, to provide fast, accurate, and multiplex diagnostic testing for respiratory and sore throat infections at the point of care, improving patient care and reducing antibiotic misuse. Rapid throat infection diagnostics involve tests, such as the rapid strep test, that quickly detect the presence of group A streptococcus bacteria in the throat, enabling timely diagnosis and treatment of strep throat. For instance, in June 2024, bioMérieux, a France-based in vitro diagnostics company, announced the launch of its BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini, a rapid diagnostic test that detects five common viral and bacterial causes of respiratory and sore throat infections, designed to provide quick, actionable results at the point of care.

Regional Outlook

North America was the largest region in the strep throat treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Strep Throat Treatment Market?

The strep throat treatment market consists of revenues earned by entities through services such as, antibiotic prescriptions, pain relief management, supportive care, and follow-up consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The strep throat treatment market also includes sales of throat lozenges and supportive care items such as throat sprays and herbal remedies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Strep Throat Treatment Market Report 2026?

The strep throat treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the strep throat treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.